美國NOVABIOS違禁品檢測試劑盒6聯(lián)卡

 我司同時提供 BZO-BAR-COC-THC -MET--OPI-OXY-MDMA-PCP- AMP-BUP-XTC-MTD 多聯(lián)（膠體金法）

NOTE:

• The intensity of color in the test region (T) may vary depending on the concentration of analytes present in the specimen. Therefore, any shade of color in the test region should be considered negative. Note that this is a qualitative test only, and cannot determine the concentration of analytes in the specimen.
• Insufficient specimen volume, incorrect operating procedure or expired tests are the most likely reasons for control band failure.美國NOVABIOS違禁品檢測試劑盒6聯(lián)卡

QUALITY CONTROL

• Good laboratory practice recommends the use of control materials to ensure proper kit performance. Quality control specimens are available from commercial sources and are recommended to be used daily. Use the same assay procedure as with a urine specimen. Controls should be challenging to the assay cutoff concentration. If control values do not fall within established limits, assay results are invalid. Users should follow the appropriate federal, state, and local guidelines concerning the running of external quality controls.
• The Drug Screen Panels provides built-in process control with a different antigen/antibody reaction at the control region (C) in each strip. This control line should always appear regardless of the presence of drug or metabolite. If the control line does not appear, the test device should be discarded. The presence of this control band in the control region serves as 1) verification that sufficient volume is added, 2) that proper flow is obtained.

LIMITATIONS OF THE TEST

• The assay is designed for use with human urine only.
• A positive result with any of the tests indicates only the presence of a drug/metabolite and does not indicate or measure intoxication.
• There is a possibility that technical or procedural error as well other substances as factors not listed may interfere with the test and cause false results. See SPECIFICITY for lists of substances that will produce either positive results, or that do not interfere with test performance.
• If a drug/metabolite is found present in the urine specimen, the assay does not indicate frequency of drug use or distinguish between drug of abuse and certain foods and medicines.

Urine Collection: The DOA Panels are formulated for use with urine specimens. Fresh urine does not require any special handling or pretreatment. The urine specimen must be collected in a clean and dry container. Urine collected at any time of the day may be used. Urine specimens exhibiting visible precipitates should be centrifuged, filtered, or allowed to settle to obtain clear specimen for testing.

Urine Storage: It is recommended the collected fresh urine to be tested immediay. Fresh urine maybe stored at room temperature (25ºC) for up to 4 hours or to be refrigerated (2-8ºC) for up to 48 hours prior to performing the test. For prolonged storage, specimens may be frozen and stored below -20ºC. Specimens that have been refrigerated must be brought to room temperature prior to testing. Previously frozen specimens must be thawed, brought to room temperature, and mixed thoroughly prior to testing. 

添加掃一掃二維碼：

【公司名稱】 廣州健侖生物科技有限公司

【  市場部 】       楊永漢
【】 
【騰訊 】
【公司地址】 廣州市清華科技園健新基地番禺石樓鎮(zhèn)健啟路63號二期2幢101-103室